News
Phase 3 study of novel pemphigus treatment is initiated
Results of a phase 2 study of the BTK inhibitor were positive.
News
Firdapse approved: First treatment for rare autoimmune disorder
Amifampridine (Firdapse) has been approved by the FDA for Lambert-Eaton myasthenic syndrome, which affects the nerves’ connection with muscles.
News
Comorbid depression, anxiety linked to doubled risk of diabetes
“This study provides further support for the notion that depression with comorbid anxiety symptoms might represent a group...
News
Physical activity tied to lower depression risk among older adults
“Meeting WHO recommended [physical activity] levels could be recommended ... to prevent the onset of depression.”
News
FDA approves Sympazan for Lennox-Gastaut syndrome
Patients with Lennox-Gastaut syndrome can have difficulty swallowing pills or large-volume oral suspensions, so this oral film may reduce care...
News
Age, insurance type tied to delay in pediatric febrile UTI treatment
Longer delays in antimicrobial treatment can lead to renal scarring, which also is more likely with older age.
News
FDA approves DNA-based blood type test
This is the first molecular-based test for red blood cell types to report genotypes in its results.
News
FDA approves emicizumab for hemophilia A without inhibitors
Emicizumab-kxwh (Hemlibra) is now approved to treat all age groups with hemophilia A, with or without factor VIII inhibitors.
News
FDA approves omadacycline for pneumonia and skin infections
The tetracycline antibiotic was approved for CABP and acute bacterial skin and skin structure infections in adults.
News
FDA approves Arikayce for MAC lung diseases
This is the first time a drug has been approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs.
News
Adalimumab safety update finds no new signals
The new integrated analysis includes safety data from five clinical trials that were not included in the analysis from 2009.